An autoradiographic study of cellular proliferaton, DNA synthesis and cell cycle variability in the rat liver caused by phenobarbital-induced oxidative stress: The protective role of melatonin

Cellular and Molecular Biology Letters

Volumn 12, Issue 3, 2007, Pages 317-330

  El Sokkary, Gamal H ^a  

^a Assiut University   (Egypt)

Author keywords

Cell cycle; Cell proliferation; DNA synthesis; Lipid peroxidation; Melatonin; Phenobarbital

Indexed keywords

MELATONIN; PHENOBARBITAL; REACTIVE OXYGEN METABOLITE; THYMIDINE; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENOTOXICITY; HORMONAL REGULATION; LABELING INDEX; LIPID PEROXIDATION; LIVER; MALE; MEASUREMENT; MITOGENESIS; NONHUMAN; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; RAT;

RATTUS;

ANIMALS; AUTORADIOGRAPHY; CELL CYCLE; CELL PROLIFERATION; DNA; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MELATONIN; OXIDATIVE STRESS; PHENOBARBITAL; PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TRITIUM;

EID: 34548016448     PISSN: 14258153     EISSN: 16891392     Source Type: Journal    
DOI: 10.2478/s11658-007-0005-2     Document Type: Article

References (60)

1. Peraino, C., Fry, R.J.M. and Staffeldt, E. Enhancement of spontaneous hepatic tumorigenesis in C3H mice by dietary Phenobarbital. J. Natl. Cancer Inst. 51 (1973) 1349-1350.
2. Clemmesen, J. and Hjalgrim-Jensen, S. Is Phenobarbital carcinogenic? A follow-up of 8078 epileptics. Ecotoxicol. Environ. Safety 1 (1978) 457-470.
3. Jirtle, R.L., Meyer, S.A. and Brockenbrough, J.S. Liver tumor promoter Phenobarbital: a biphasic modulator or hepatocyte proliferation. Prog. Clin. Biol. Res. 369 (1991) 209-216.
4. Tsai, W.H. and DeAngelo, A.B. Responsiveness hepatocytes from dichloroacetic acid or phenobarbital treated mice to growth factors in primary cultures. Cancer Lett. 99 (1996) 177-183.
5. Jones, H.B., Clarke, N.A. and Barras, N.C. Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry. J. Histochem. Cytochem. 41 (1993) 21-27.
6. Peraino, C., Fry, R.J.M., Staffeldt, E. and Christopher, J.P. Comparative enhancing effects of Phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyl-trichloroethane on 2-acetylaminofluorene induced hepatic tumourigenesis in rat. Cancer Res. 35 (1975) 2884-2890.
7. Shelby, M.D. and Zieger, E. Activity of human carcinogens in the salmonella and rodent bone-marrow cytogenetics tests. Mutat. Res. 234 (1990) 257-261.
8. Butterworth, B.E., Popp, J.A., Conolly, R.B. and Goldsworthy, T.L. Chemically induced cell proliferation in carcinogenesis. in: Mechanisms of Carcinogenesis in Risk Identification. Scientific Publications (Vainio, H., Magee, P.N., McGregor, D.B.and McMichael, A.J. Eds.), Lyon, France, 1992, 279-305.
9. Schulte-Hermann, R., Bursch, W., Grasl-Kraupp, B., Torok, L., Ellinger, A. and Mullauer, L. Role of active cell death (apoptosis) in multi-stage carcinogenesis. Toxicol. Lett. 82/83 (1995) 143-148.
10. Butterworth, B.E., Conolly, R.B. and Morgan, K.T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 93 (1995) 129-146.
11. Melnick, R. and Huff, J. Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation. Toxicol. Indust. Health 9 (1993) 415-438.
12. Columbano, A., Ledda-Columbano, G., Coni, P., Pichiri-Coni, G., Curto, M. and Pani, P. Chemically induced cell proliferation and carcinogenesis: Differential effect of compensatory cell proliferation and mitogen-induced direct hyperplasia on hepatocarcinogenesis in the rat. in: Chemically Induced Cell Proliferation: Implications for Risk Assessment (Butterworth, B., Slaga, T., Farland, W. and McClain, M. Eds.), Wiley-Liss, New York. 1991, 217-225.
13. Bursch, W., Fesus, L. and Schulte-Hermann, R. Apoptosis ('Programmed' cell death) and its relevance in liver injury and carcinogenesis. in: Tissue-Specific Toxicity Biochemical Mechanisms (Dekant, W. and Neumann, H. Eds.), Academic Press, London. 1992, 95-115.
14. Goldsworthy, T., Fransson-Steen, R. and Maronpot, R. Importance of and approaches to quantification of hepatocyte apoptosis. Toxicol. Pathol. 24 (1996) 24-35.
15. Stark, A.A., Russell, J.J., Langenbach, R., Pagano, D.A., Zeiger, E. and Huberman, E. Localization of oxidative damage by a glutathione-γ-glutamyl transpeptidase system in neoplastic lesions in sections of livers from carcinogen-treated rats. Carcinogenesis 15 (1994) 343-348.
16. Imaoka, S., Osada, M., Minamiyama, Y., Yukimura, T., Toyokuni, S., Takemura, S., Hiroi, T. and Funae, Y. Role of Phenobarbital-induced cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett. 203 (2004) 117-125.
17. Diez-Fernandez, C., Sanz, N., Alvarez, A.M., Wolf, A. and Cascales, M. The effect of non-genotoxic carcinogens, phenobarbital and clofibrate, on the relationship between reactive oxygen species, antioxidant enzyme expression and apoptosis. Carcinogenesis 19 (1998) 1715-1722.
18. Venditti, R., Daniele, C.M., Deleo, T. and DiMeo, S. Effect of phenobarbital treatment on characteristics determining susceptibility to oxidants of homogenates, mitochondria and microsomes from rat liver. Cell Physiol. Biochem. 8 (1998) 328-338.
19. Aniya, Y., Shimoji, M. and Naito, A. Increase in liver microsomal glutathione-S-transferase activity by phenobarbital treatment of rats: possible involvement of oxidative activation via cytochrome P450. Biochem. Pharmacol. 46 (1993) 1741-1747.
20. Saintot, M., Astre, C., Pujol, H. and Gerber, M. Tumor progerssion and oxidant antioxidant status. Carcinogenesis 17 (1996) 1267-1271.
21. Wolfle, D. and, Marquardt, H. Antioxidants inhibit the enhancement of malignant cell transformation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Carcinogenesis 17 (1996) 1273-1278.
22. Whisler, R.L., Goyette, M.A., Grants, J.S. and Newhouse, Y.G. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in jurkat T cells. Arch. Biochem. Biophys. 319 (1995) 23-25.
23. Kass, G.E.N.,. Free radical induced changes in cell signal transduction. in: Free radical Toxicology (Wallace, K.B. Ed.), Taylor and Francis, Washington, DC, 1997, 349-374.
24. Reiter, R.J. Oxidative damage in the central nervous system: Protection by melatonin. Prog. Neurobiol. 56 (1998) 359-384.
25. Reiter, R.J. Melatonin: Lowering the high price of free radicals. News Physiol. Sci. 15 (2000) 246-250.
26. El-Sokkary, G.H. Melatonin protects against oxidative stress induced by the kidney arcinogen KBrO3. Neuroendocrinol. Lett. 21 (2000) 461-468.
27. El-Sokkary, G.H. Inhibition of 2-nitropropane-induced cellular proliferation, DNA synthesis and histopathological changes by melatonin. Neuroendocrinol. Lett. 23 (2002) 335-340.
28. El-Sokkary, G.H.; Reiter, R.J. and Abdel Ghaffar, S.Kh. Melatonin supplementation restores cellular proliferation and DNA synthesis in the splenic and thymic lymphocytes of old rats. Neuroendocrinol. Lett. 24 (2003) 215-223.
29. El-Sokkary, G.H., Abdel-Rahman, G.H. and Kamel, E.S. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 213 (2005) 25-33.
30. Abd-Elghaffar, S.Kh, El-Sokkary, G.H. and Sharkawy, A.A. Aluminium-induced neurotoxicity and oxidative damage in rabbits: Protective effect of melatonin. Neuroendocinol. Lett. 26 (2005) 609-616.
31. Martinez-Cruz, F., Osuna, C. and Guerrero, J.M. Mitochondrial damage induced by fetal hyperphenylalaniemia in the rat brain and liver: Its prevention by melatonin, vitamin E and vitamin C. Neurosci. Lett. 392 (2006) 1-4.
32. Hamatani, K., Kawahara, A. and Amano, M. Quantitative study of deoxycytidine incorporation in large and small lymphocytes of the mouse. Cell Tissue Kinet. 16 (1983) 557-570.
33. Sadava, D.E. Cell cycle. in: Cell Biology, Organelle Structure and Function. Jones and Bartlett Publishers, 1993, 442-496.
34. Jirtle, R.L. and Meyer, S.A. Liver tumor promotion: effect of phenobarbital on EGF and protein kinase C signal transduction and TGFβ1 expression. Dig. Dis. Sci. 36 (1991) 659-668.
35. Guppy, M.J., Wilton, J.C., Sharma, R. and Chipman, J.K. Modulation of phenobarbitone induced loss of gap junctional intercellular communication in hepatocyte couplets. Carcinogenesis 15 (1994) 1917-1921.
36. Bock, K.W., Lipp, H.P. and Bock-Hennig, B.S. Induction of drug-metabolizing enzymes by xenobiotics. Xenobiotica 20 (1990) 1101-1111.
37. Murkofsky, R.L., Glover, S.E., Miller, R.T., Popp, J.A. and Cattley, R.C. Effect of regeneration and hyperplasia on levels of DNA base oxidation in rat liver. Cancer Lett. 70 (1993) 51-56.
38. Kinoshita, A., Wanibuchi, H., Imaoka, S., Ogawa, M., Masuda, C., Morimura, K., Funae, Y. and Fukushima, S. Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: association with expression profiles of p21 WAF1/Cip1, cyclin D1 and Ogg1. Carcinogenesis 23 (2002) 341-349.
39. Kaufmann, W.K., Ririe, D.G. and Kaufman, D.G. Phenobarbital-dependent proliferation of putative initiated rat hepatocytes. Carcinigenesis 9 (1988) 779-782.
40. Arora, V.K., Bhatia, A. and Sood, S.K. Synergistic promoter effect of diethylstilbesterol & phenobarbitone in diethylnitrosamine induced hepatic neoplasia in rats. Indian J. Med. Res. 90 (1989) 9-16.
41. Weghorst, C.M. and Klaunig, J.E. Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice. Influence of gender. Carcinogenesis 10 (1989) 609-612.
42. Debiec-Rychter, M. and Wang, C.Y. Induction of urinary bladder of the F344 rat. Toxicol. Appl. Pharmacol. 105 (1990) 345-349.
43. Morsi, G.A. Autoradiographic studies on the effect of sodium phenobarbital on the kinetics of DNA synthesis in the hepatocytes of male albino rat. Egypt. J. Histol. 14 (1991) 511-523.
44. Gonzales, J.A., Christensen, J.G., Preston, R.J., Goldsworthy, T.L., Tlsty, T.D. and Fox, T.R. Attenuation of G1 checkpoint function by the non-genotoxic carcinogen Phenobarbital. Carcinogenesis 19 (1998) 1173-1183.
45. Hartwell, L.H. and Weinhert, T.A. Checkpoints: Controls that ensure the order of cell cycle events. Science 246 (1989) 629-633.
46. Kaufmann, W.K. and Wilson, S.R. G1 arrest during cell cycle dependent clastogenesis in UV-irradiated human fibroblasts. Mutat. Res. 314 (1994) 67-76.
47. Livingstone, L.R., White, A., Sprouse, J., Livanos, E., Jacks, T. and Tlsty, T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 (1992) 923-935.
48. White, A.E., Livanos, E.M. and Tlsty, T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8 (1994) 666-677.
49. Hartwell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71 (1992) 543-546.
50. Tan, D.X., Chen, L.D., Poeggeler, B., Manchester, L.C. and Reiter, R.J. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr. J. 1 (1993) 57-60.
51. Reiter, R.J., Tan, D.X., Qi, W., Manchester, L.C., Karbownik, M. and Calvo, J.R. Pharmacology and physiology of melatonin in reduction of oxidative stress in vivo. Biol. Signals Recept. 9 (2000) 160-171.
52. Cardinali, D.P., Borfman, G. P., Liotta, G., Perez Floret, S., Albornoz, L.E., Cutrera, R.A., Batista, J. and Ortiga, G.B. A multifactorial approach employing melatonin to accelerate resynchronization of sleep-wake cycle after a 12 time-zone westerly transmeridian flight in elite soccer athletes. J. Pineal Res. 32 (2002) 41-46.
53. Cardinali, D.P. Clinical perspectives for the use of melatonin as a neuroprotective chronobiotic in Alzheimer's disease. Aktual. Neurol. 3 (2003) 188-204.
54. Blask, D.E., Sauer, L.A. and Dauchy, R.T. Melatonin as a chronobiotic/anticancer agent. Curr. Top. Med. Chem. 2 (2002) 113-132.
55. Cos, S. and Sanchez-Barcelo, E.J. Melatonin inhibition of MCF-7 human breast cancer cells growth: influence of cell proliferation rate. Cancer Lett. 93 (1995) 207-212.
56. Persengiev, S.P. and Kyurkchiev, S. Selective effect of melatonin on the proliferation of lymphoid cells. Int. J. Biochem. 25 (1993) 441-444.
57. Malamud, D. The cell cycle and cancer. (Baserga, R. Ed.), Cold Spring Harbor, New York. 1971, 132-141.
58. Crespo, D., Fernandez-Viadero, C., Verduga, R., Ovejero, V. and Cos, S. Interaction between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J. Pineal Res. 16 (1994) 215-222.
59. Jayat, C. and Ratinaud, M.H. Cell cycle analysis by flow cytometry: Principles and Applications. Biol. Cell 78 (1993) 15-25.
60. Cos, S., Blask, D.E., Lemus-Wilson, A. and Hill, A.B. Effects of melatonin on the cell cycle kinetics and estrogen rescue of MCF-7 human breast cancer cells in culture. J. Pineal Res. 10 (1991) 36-43.